Necrotizing Autoimmune Myopathy [Test in Focus] - Insights
Necrotizing autoimmune myopathy (NAM) is a serious but rare muscle disease strongly associated with autoantibodies to either the protein signal recognition particle (SRP) or the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase...
Engaging the Next Generation of Lab Professionals - Insights
In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, Isak joins the Mayo Clinic Laboratories outreach team — Jane Hermansen, Ellen Dijkman Dulkes, and Brianne Newton — to talk about his unique experience in...
Early-Onset IBD: Genetic Testing and Clinical Applications - Insights
Identification of early-onset IBD patients may enable tailored treatment and surveillance plans. With over 50 genes implicated in early-onset IBD, genetic testing should be included in the workup of children under the age of six with IBD....
Phlebotomy Lab Operations - Insights
PACE / State of FL Phlebotomy and specimen collection services are on the forefront of patient diagnosis. However, more often than not, they are over shadowed by testing laboratories because they deliver the final test results. The focus of...
Challenging Patient Encounters - Insights
PACE This “Phlebotomy Webinar” will discuss real-world examples of patient behavior deemed unsafe and/or disrespectful and best practices for resolution.
New tests launched in April - Insights
In April 2023, Mayo Clinic Laboratories announced 10 new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Improvements to downtime process, form provide clarity for clients - Insights
The downtime process and form have been improved to provide clear guidance on the steps clients should take during downtime.
Mayo Clinic Laboratory and pathology research roundup: April 19 - Insights
Top highlights include: Advances in neuroimaging for brain charts for the human lifespan.
Winter Storm Kingston - Insights
Due to weather affecting the FedEx hub in Memphis, TN, FedEx has initiated its contingency plan and expects delays. Mayo Clinic Laboratories’ Global Logistics team will proactivelymove work from FedEx to other commercial shipping options.
Mayo Clinic Laboratories releases new, first-to-U.S.-market pregnancy risk assessment - Insights
Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe...